Washington · Nonprofit
FRED HUTCHINSON CANCER RESEARCH CENTER
FRED HUTCHINSON CANCER RESEARCH CENTER (Washington) receives grants from 405 organizations whose IRS filings report $333,541,450 to it, the largest being GATES FOUNDATION ($120,008,815). 254 of them have funded it in more than one year.
- Revenue FY2022
- $697M
- Funders on record
- 405
- Grants received
- $334M
- Net assets
- $0
What Fred Hutchinson Cancer Research Center does
Mission
Our researchers are pushing the limits of human knowledge, from foundational biology to population-level health. Through fearless science, collaboration across disciplines, and unshakable focus, we're leading the way to a world free of cancer and related diseases.
As stated on its FY2022 Form 990.
Programs
Vaccine and infectious disease division (vidd): vidd integrates the latest in computational, laboratory and clinical research methods to advance the understanding of microbial pathogenesis and infectious disease processes. Vidd researchers partner with scientists at laboratory, clinical and field sites in the americas, africa, asia and europe. The division has specific initiatives in uganda, china and the republic of south africa to advance the understanding of infection-related cancers and infectious diseases that affect high-risk populations in these regions. Vidd scientists around the world, including clinicians, clinical trial specialists, statisticians, computational biologists and basic scientists, take pride in their collaborative efforts to predict, detect, treat and prevent infectious diseases in humans, including known and emerging infections of major global health importance, such as coronavirus, and cancer-related infectious diseases.
$281,420,625 spentof which $86,049,600 as grants$28,604,468 earned by the program51% of program spendingClinical research division:the clinical research division conducts laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our clinical researchers are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
$120,087,117 spentof which $36,718,874 as grants$12,206,028 earned by the program22% of program spendingPublic health sciences division:the public health sciences division identifies strategies that would ultimately reduce the incidence of and mortality from cancer and other diseases. Using large populations as their "laboratory," our public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors. Identifying such cancer causes can lead to better cancer-detection methods and new ways to help people adopt healthier lifestyles to minimize or avoid their risk of getting the disease in the first place. Our statistical, computational, epidemiological, translational and prevention projects include studies around the world.
$87,467,133 spentof which $26,744,705 as grants$8,890,432 earned by the program16% of program spendingHuman biology division:the human biology division integrates fundamental, applied and translational science to improve the diagnosis, treatment and prevention of cancer and other diseases. Human biology researchers come together to form a multidisciplinary team that is influenced by individual advances. Their diverse expertise include molecular and cell biology, genomics, genetics, virology, infectious disease, computational biology, pathology and clinical research. Grounded in high-quality basic science, the research performed in human biology blends research performed in model organisms and in vitro systems.
$36,676,463 spentof which $11,214,513 as grants$3,727,910 earned by the program7% of program spendingBasic sciences division:the basic sciences division answers fundamental biological questions and produces new insights on the basic biology of life processes and the development of complex diseases like cancer. Our faculty include investigators working in diverse areas related to all aspects of biology, including gene regulation and genomic integrity, neuroscience, immunology and evolution, biophysics and quantitative biology, and cell proliferation and fate.
$26,857,390 spentof which $8,212,148 as grants$2,729,869 earned by the program5% of program spending
The 5 programs described on its FY2021 Form 990, listed largest first by expense. Program spending in total: $552,508,728.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $1.7B to $0 (−100%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2017 70% · 2018 50% · 2019 65% · 2020 71% · 2021 78% · 2022 72%. Grants only. Government contracts and fees sit inside program revenue.
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 6 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Board chair
Kathy Surace-Smith
Chair
As listed on its FY2022 Form 990.
Who funds it, year by year
2017 → 2023: the base narrowed from 133 funders to 115 funders, grant income fell $47M → $24M.
42 of 405 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 11% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $54M from 26 payers (the payer shares this organization's board, largest Seattle Children's Hospital). These are real filings, and they are not money FRED HUTCHINSON CANCER RESEARCH CENTER raised.
From the IRS filings of FRED HUTCHINSON CANCER RESEARCH CENTER’s funders (the co-funder graph). Top 30 of 405 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
FRED HUTCHINSON CANCER RESEARCH CENTER has a broad base — no single funder exceeds 36% of grant income, and it takes 7 funders to reach half.
the vertical line marks half of all grant income — 7 funders to its left
41% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund FRED HUTCHINSON CANCER RESEARCH CENTER.
Largest funder’s share by year: 2017 47% · 2018 66% · 2019 62% · 2020 41% · 2021 25% · 2022 7% · 2023 7% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
39% of FRED HUTCHINSON CANCER RESEARCH CENTER's funders are still giving 3 years after their first grant; 63% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
56% of FRED HUTCHINSON CANCER RESEARCH CENTER's grant income comes from Washington funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $36M arriving through sponsors registered in 24 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Government funding FRED HUTCHINSON CANCER RESEARCH CENTER receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $2.3B on record.
- Department of Health and Human Services$2.2B
- Department of Defense$41.3M
- National Science Foundation$3.3M
- Department of Agriculture$1.0M
- Department of Veterans Affairs$948k
- Department of the Interior$63k
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like FRED HUTCHINSON CANCER RESEARCH CENTER
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
91% of spending goes to programs.
Governance
Public support
92%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 50 states
Part of a family of 6 related entities
- Fred Hutchinson International LLC · disregarded
- Seattle Vaccine Research Fund · exempt
- Hutchinson Centre Research Institute of Uganda Limited · exempt
- Hutchinson Centre Research Institute of South Africa · exempt
- Charitable Remainder Trusts (7) · corp_trust
Screen this organization
A dated, signed PDF of the compliance screen for FRED HUTCHINSON CANCER RESEARCH CENTER: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds FRED HUTCHINSON CANCER RESEARCH CENTER?
- FRED HUTCHINSON CANCER RESEARCH CENTER (Washington) receives grants from 405 organizations whose IRS filings report $333,541,450 to it, the largest being GATES FOUNDATION ($120,008,815). 254 of them have funded it in more than one year.
- How many funders does FRED HUTCHINSON CANCER RESEARCH CENTER have?
- IRS filings report 405 organizations giving $333,541,450 in grants to FRED HUTCHINSON CANCER RESEARCH CENTER, 254 of which have funded it in more than one year.
- Who is the largest funder of FRED HUTCHINSON CANCER RESEARCH CENTER?
- GATES FOUNDATION is the largest funder on record, with $120,008,815 in grants. The full list of funders is on this page.
- How can an organization like FRED HUTCHINSON CANCER RESEARCH CENTER find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2022 (financials across 2017–2022), and the filings of 405 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing